Results 251 to 260 of about 1,923,312 (279)

Incidence of Respiratory Syncytial Virus Infection among Hospitalized Adults, 2017-2020.

Clinical Infectious Diseases, 2021
BACKGROUND Respiratory syncytial virus (RSV) infection causes acute respiratory illness and triggers exacerbations of cardiopulmonary disease. Estimates of RSV incidence in hospitalized adults range widely, and few data exist on incidence in adults with ...
A. Branche, L. Saiman, E. Walsh, A. Falsey, W. Sieling, W. Greendyke, Derick R. Peterson, C. Vargas, M. Phillips, L. Finelli   +9 more
semanticscholar   +1 more source

The role of respiratory syncytial virus‐ and rhinovirus‐induced bronchiolitis in recurrent wheeze and asthma—A systematic review and meta‐analysis

Pediatric Allergy and Immunology, 2022
Respiratory syncytial virus (RSV) is the most common cause of bronchiolitis. RSV‐induced bronchiolitis has been associated with preschool wheeze and asthma in cohort studies where the comparison groups consist of healthy infants.
Heidi Makrinioti, K. Hasegawa, J. Lakoumentas, P. Xepapadaki, M. Tsolia, J. Castro-Rodríguez, W. Feleszko, T. Jartti, S. Johnston, A. Bush, V. Papaevangelou, C. Camargo, N. Papadopoulos   +12 more
semanticscholar   +1 more source

Respiratory syncytial virus (RSV) vaccine effectiveness against RSV-associated hospitalisations and emergency department encounters among adults aged 60 years and older in the USA, October, 2023, to March, 2024: a test-negative design analysis

The Lancet
Summary Background Respiratory syncytial virus vaccines first recommended for use during 2023 were efficacious against lower respiratory tract disease in clinical trials. Limited real-world data regarding respiratory syncytial virus vaccine effectiveness
A. Payne, Janet A Watts, Patrick K Mitchell, Kristin Dascomb, Stephanie A. Irving, Nicola P. Klein, S. Grannis, Toan C. Ong, Sarah W. Ball, M. DeSilva, Karthik Natarajan, Tamara Sheffield, Daniel Bride, Julie Arndorfer, A. Naleway, Padma Koppolu, B. Fireman, O. Zerbo, J. Timbol, Kristin Goddard, Brian E. Dixon, William F. Fadel, Colin Rogerson, Katie S Allen, S. Rao, David Mayer, M. Barron, S. E. Reese, E. Rowley, M. Najdowski, A. Ciesla, Josephine Mak, Emily L. Reeves, Omobosola O. Akinsete, C. Mcevoy, Inih J. Essien, M. Tenforde, Katherine E. Fleming-Dutra, R. Link-Gelles   +38 more
semanticscholar   +1 more source

Early-life respiratory syncytial virus disease and long-term respiratory health.

The Lancet Respiratory Medicine
Respiratory syncytial virus (RSV) is a leading cause of lower respiratory tract infection (LRTI), hospital admission, and mortality in children worldwide.
H. Zar, F. Cacho, Tahira Kootbodien, A. Mejías, J. R. Ortiz, Renato T. Stein, T. Hartert   +6 more
semanticscholar   +1 more source

Respiratory syncytial virus infection in adults

British medical journal, 2019
Human respiratory syncytial virus (RSV) belongs to the recently defined Pneumoviridae family, Orthopneumovirus genus. It is a negative sense, single stranded RNA virus that results in epidemics of respiratory infections that typically peak in the winter ...
Hannah H. Nam, M. Ison
semanticscholar   +1 more source

Respiratory syncytial virus infection and novel interventions

Nature Reviews Microbiology, 2023
A. Langedijk, L. Bont
semanticscholar   +1 more source

Respiratory Syncytial Virus Infection: An Update

Indian Journal of Pediatrics, 2023
Akshita Soni, S. Kabra, R. Lodha
semanticscholar   +1 more source

Functional Features of the Respiratory Syncytial Virus G Protein

Viruses, 2021
Suxiang Tong, Clinton Paden, Larry Anderson   +2 more
exaly